By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Cyclacel Pharmaceuticals, Inc. 

200 Connell Drive
Suite 1500
Berkeley Heights  New Jersey  07922  U.S.A.
Phone: 908-517-7330 Fax: 866-271-3466


SEARCH JOBS

Cyclacel Pharmaceuticals is a biopharmaceutical company developing oral therapies that target the various phases of cell cycle control for the treatment of cancer and other serious diseases.

YEAR FOUNDED:

1996

LEADERSHIP:

Founder: Sir David Lane

CEO: Spiro Rombotis

JOBS:

Please click here for Cyclacel job opportunities.

CLINICAL TRIAL:

Please click here for clinical trial information.


Key Statistics


Email: info@cyclacel.com
Ownership: Public

Web Site: Cyclacel Pharma
Employees:
Symbol: CYCC
 









Company News
The Reason Penny Stock Cyclacel Pharma (CYCC)'s Share Price Doubled the Past 10 Days 8/23/2016 6:18:47 AM
Cyclacel Pharma (CYCC) Reports 2nd Quarter 2016 Financial Results 8/11/2016 10:56:35 AM
Cyclacel Pharma (CYCC) To Release Second Quarter 2016 Financial Results 8/3/2016 7:47:43 AM
Cyclacel Pharmaceuticals, Inc. (CYCC)’s CYC065 Demonstrates Promising Activity In Uterine Serous Carcinoma In Preclinical Data Published By Independent Academic Researchers 8/2/2016 8:11:49 AM
Cyclacel Pharmaceuticals, Inc. (CYCC) Regains Compliance With Nasdaq Continued Listing Requirements 6/16/2016 10:48:32 AM
ASCO2016: Cyclacel Pharmaceuticals, Inc. (CYCC) Reports Updated Data From Its DNA Damage Response Program On Seliciclib And Sapacitabine Combination In Patients With Solid Tumors At ASCO 6/6/2016 3:53:49 PM
Cyclacel Pharmaceuticals, Inc. (CYCC) Announces Reverse Stock Split 5/31/2016 10:11:35 AM
Cyclacel Pharmaceuticals, Inc. (CYCC)'s Seliciclib-Sapacitabine Abstract Selected For Oral Presentation At The 2016 ASCO Annual Meeting 5/19/2016 10:19:08 AM
Cyclacel Pharmaceuticals, Inc. (CYCC) Reports First Quarter 2016 Financial Results 5/12/2016 8:40:59 AM
Cyclacel Pharmaceuticals, Inc. (CYCC) To Release First Quarter 2016 Financial Results 5/4/2016 7:53:29 AM
12345678910...
//-->